Parkinson’s UK celebrity ambassador David ‘Kid’ Jensen takes part in world-first clinical trial
Broadcasting legend and Parkinson's UK celebrity ambassador David ‘Kid’ Jensen is taking part in a world-first clinical trial. The trial will help researchers understand if an anti-sickness drug could treat hallucinations in people with Parkinson’s or Lewy body dementia.
Understanding symptoms early after Parkinson’s diagnosis
An important research partnership involving Parkinson’s UK, pharmaceutical company UCB and the Parkinson’s Foundation has published their first results in a study designed alongside people living with Parkinson’s.
Progress towards Apple Watch based tracking of symptoms
An app that links to Apple Watch technology has been granted FDA approval to help monitor some motor symptoms experienced by people with Parkinson’s.
Save Parkinson’s clinical research. Take part today
We’re calling on the Parkinson’s community to take part in 5 important clinical studies that are currently at risk of closure.
Celebrating neuroscience in spring 2023
We are partnering with the British Neuroscience Association (BNA) to plan and deliver the BNA International Festival of Neuroscience 2023. Drawing together leading neuroscientists, including Parkinson’s researchers, from across the globe to celebrate and share the latest thinking in neuroscience today.
NRG Therapeutics awarded £2.68m to develop treatments that could slow Parkinson's
Biotech company, NRG Therapeutics, has today announced an Innovate UK award to continue its drug development project, supported by the Parkinson's Virtual Biotech, into life-changing new treatments.
Researchers find brain scans linked to the severity of Parkinson’s symptoms
Research led by Cambridge University and part funded by Parkinson’s UK shows that a form of brain scan could help identify those at risk of specific Parkinson’s symptoms. The results could pave the way to better treatment of Parkinson’s.
Clinical trial of world’s smallest deep brain stimulation device hits headlines
A trial of a new miniaturised deep brain stimulation (DBS) device, being carried out at Southmead Hospital in Bristol, aims to make improvements to existing surgery.
Progress made in partnership between pharma and people with Parkinson's
A pioneering partnership between global biopharmaceutical company UCB, Parkinson’s UK and the Parkinson's Foundation in the US is laying the foundations for people with Parkinson's to feed into the drug development pipeline.